Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
55.13
-2.24 (-3.90%)
Nov 15, 2024, 4:00 PM EST - Market closed
Revolution Medicines Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$57.00
Upside
+3.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $61 → $68 | Strong Buy | Maintains | $61 → $68 | +23.34% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $62 → $64 | Strong Buy | Maintains | $62 → $64 | +16.09% | Nov 7, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $54 → $63 | Buy | Maintains | $54 → $63 | +14.28% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $57 → $70 | Buy | Maintains | $57 → $70 | +26.97% | Nov 7, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $72 → $82 | Strong Buy | Maintains | $72 → $82 | +48.74% | Oct 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $55 → $60 | Buy | Maintains | $55 → $60 | +8.83% | Oct 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +10.65% | Oct 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +10.65% | Oct 25, 2024 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +10.65% | Oct 24, 2024 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +10.65% | Oct 7, 2024 |
| Barclays | Barclays | Buy Maintains $54 → $60 | Buy | Maintains | $54 → $60 | +8.83% | Sep 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +1.58% | Aug 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $55 → $54 | Buy | Maintains | $55 → $54 | -2.05% | Aug 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $59 | Buy | Reiterates | $59 | +7.02% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Maintains $62 → $61 | Strong Buy | Maintains | $62 → $61 | +10.65% | Aug 8, 2024 |
| Barclays | Barclays | Buy Maintains $52 → $54 | Buy | Maintains | $52 → $54 | -2.05% | Jul 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.